Biopsy site marker
A biopsy site marker configured to expand upon deployment into a biopsy cavity, and visible under several different imaging modalities, comprises a superabsorbent hydrogel component and a radiopaque element. The hydrogel is in a compressed, dehydrated state prior to deployment to facilitate placement of the marker within the biopsy site, and thereafter expands upon deployment in the biopsy site. Such expansion limits migration of the site marker.
1. A detectable marker for implantation in a targeted site, the marker comprising:
an outer portion formed by polymeric threads and defining an interior region, wherein, upon implantation in the targeted site, the outer portion is configured to transition from a collapsed shape to an expanded shape, the expanded shape being different than the collapsed shape and defining a hyperechoic region of the marker; and a hydrogel body contained within the interior region of the outer portion of the marker, the hydrogel body being configured to transition between a pre-deployment configuration and a post-deployment configuration when exposed to a fluid, and to provide a hypoechoic region of the marker,
wherein, in the post-deployment configuration, the hydrogel body swells to a final, fully expanded size, and
wherein, when the hydrogel body is in the final, fully expanded size, the hydrogel body fills less than an entirety of the interior region of the expanded shape of the outer portion of the marker.
2. The marker of claim 1 , wherein the outer portion of the marker comprises a braided, woven or mesh structure.
3. The marker of claim 1 , wherein the polymeric threads comprise polyethylene fibers.
4. The marker of claim 1 , wherein the hydrogel body comprises one or more of poly ( 2 -hydroxyethyl methacrylate) (pHEMA), Polyvinylpyrrolidone (PVP), poly (ethylene glycol) diacrylate (PEGDA), and Polyvinyl alcohol (PVA).
5. The marker of claim 1 , wherein the polymeric threads include a radiopacifier-loaded fiber.
6. The marker of claim 1 , wherein the polymeric threads include radiopaque and polyester threads.
7. The marker of claim 1 , wherein the expanded shape of the outer portion of the marker is a torpedo-like or teardrop-like shape.
8. The marker of claim 1 , wherein the expanded shape of the outer portion of the marker is different than a shape of the hydrogel body in the post-deployment configuration when the hydrogel body is in the final, fully expanded size.
9. The marker of claim 8 , wherein the shape of the hydrogel body in the post-deployment configuration is a cylindrical shape.
10. The marker of claim 1 , wherein the expanded shape of the outer portion of the marker comprises:
a length extending between a first end of the outer portion and a second end of the outer portion; and
a diameter that varies along the length, wherein a maximum diameter of the outer portion is located closer to the first end of the outer portion than the second end of the outer portion.
11. The marker of claim 10 , wherein the length is about 1.0 cm, and the maximum diameter is about 0.5 cm.
12. The marker of claim 1 , wherein the hyperechoic region is configured to provide a distinct outline around the hypoechoic region under ultrasound imaging of the marker.
13. A detectable marker for implantation in a targeted site, the marker comprising:
a radiopaque outer portion defining an interior region of the marker, the radiopaque outer portion being movable from a collapsed shape to an expanded shape and defining a hyperechoic region of the marker; and
a hydrogel body disposed within the interior region of the radiopaque outer portion, the hydrogel body being configured to swell to a final, fully swelled shape when exposed to a fluid, the final, fully swelled shape of the hydrogel body being configured to partially fill the interior region of the marker, such that the final, fully swelled shape of the hydrogel body is different than the expanded shape of the radiopaque outer portion of the marker, and
wherein the hydrogel body is configured to provide a hypoechoic region of the marker, the hypoechoic region being distinguishable from the hyperechoic region under ultrasound imaging of the marker.
14. The marker of claim 13 , wherein the radiopaque outer portion comprises a braided, woven or mesh structure.
15. The marker of claim 13 , wherein the radiopaque outer portion comprises polymeric threads including polyethylene fibers.
16. The marker of claim 13 , wherein the hydrogel body comprises one or more of poly ( 2 -hydroxyethyl methacrylate) (pHEMA), Polyvinylpyrrolidone (PVP), poly (ethylene glycol) diacrylate (PEGDA), and Polyvinyl alcohol (PVA).
17. The marker of claim 13 , wherein the radiopaque outer portion comprises polymeric threads including a radiopacifier-loaded fiber.
18. The marker of claim 13 , wherein the final, fully swelled shape of the hydrogel body is a cylindrical shape.
19. The marker of claim 13 , wherein the expanded shape of the radiopaque outer portion comprises:
a length extending between a first end of the radiopaque outer portion and a second end of the radiopaque outer portion; and
a diameter that varies along the length, wherein a maximum diameter of the radiopaque outer portion is located closer to the first end of the radiopaque outer portion than the second end of the radiopaque outer portion.
20. The marker of claim 13 , wherein the final, fully swelled shape of the hydrogel body is different than a shape of the interior region of the radiopaque outer portion.